(Q81057077)

English

Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand

scientific article published on 11 August 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

Nattawat Onlamoon

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Kovit Pattanapanyasat

6

object named as

Kovit Pattanapanyasat

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Sutchana Tabprasit

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Surapol Suwanagool

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Suda Louisirirotchanakul

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Aftab A Ansari

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

11 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

341

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

238-247

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Prospective Study of CD8+ Lymphocyte Activation in Relation to Viral Load in HIV-Infected Patients with >=400 CD4+ Lymphocytes per Microliter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Signal amplification in flow cytometry using biotin tyramine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Understanding HIV-1 drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Enzymatic amplification staining for flow cytometric analysis of cell surface molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Detection of low-abundance membrane markers by immunofluorescence--a comparison of alternative high-sensitivity methods and reagents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Human CD38, a cell-surface protein with multiple functions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Therapeutic drug monitoring of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

CD38 Expression in CD8+T Cells Predicts Virological Failure in HIV Type 1–Infected Children Receiving Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Magnetofluorescent liposomes for increased sensitivity of immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Detection by immunofluorescence of surface molecules present in low copy numbers high sensitivity staining and calibration of flow cytometer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.07.018

7 January 2021

Identifiers

10.1016/J.VIROL.2005.07.018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099011%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81057077&oldid=1749631628"